Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2
Open accessThe DOI matches its Crossref record.
Abstract
Leishmania donovani is the etiologic agent of fatal visceral leishmaniasis in man. During their life cycle,Leishmania exist as flagellated promastigotes within the sandfly vector and as nonflagellated amastigotes in the macrophage phagolysosomal compartment of the mammalian host. The transformation from promastigotes to amastigotes is a critical step for the establishment of infection, and the molecular basis for this transformation is poorly understood. To define the molecular basis for amastigote survival in the mammalian host, we previously identified an amastigote stage-specific gene family termed “A2.” In the present study, we have inhibited the expression of A2 mRNA and A2 protein in amastigotes using antisense RNA and show that the resulting A2-deficient amastigotes are severely compromised with respect to virulence in mice. Amastigotes that did survive in the mice had restored A2 protein expression. These data demonstrate that A2 protein is required for L. donovani survival in a mammalian host, and this represents the first identified amastigote-specific virulence factor identified in Leishmania. This study also reveals that it is possible to study gene function in Leishmania through the expression of antisense RNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bañuls, A.-L., Hide, M., & Prugnolle, F. (2007) · Advances in Parasitology · doi:10.1016/s0065-308x(06)64001-3 · Cited by 365
Yao, C., Donelson, J. E., & Wilson, M. E. (2003) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(03)00211-1 · Cited by 311
The immune response to Leishmania: mechanisms of parasite control and evasion
Bogdan, C., & Röllinghoff, M. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00169-0 · Cited by 292
Robinson, K. A., & Beverley, S. M. (2003) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(03)00079-3 · Cited by 284
McMahon‐Pratt, D., & Alexander, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00190.x · Cited by 283
Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics
Debrabant, A., Joshi, M. B., Pimenta, P. F. P., & Dwyer, D. M. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.10.011 · Cited by 215
“In order to assess whether the A2 proteins were expressed by Ld 1S-CL2DAxAm total cell lysates of these axenic amastigotes and of promastigotes were analysed by SDS-PAGE and Western blotting using a specific anti-A2 antibody (Zhang and Matlashewski, 1997).”
MethodResultInfluentialSaxena, A., Lahav, T., Holland, N., Aggarwal, G., Anupama, A., Huang, Y., Volpin, H., Myler, P. J., & Zilberstein, D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.11.011 · Cited by 160
Contreras, I., Gómez, M. A., Nguyen, O., Shio, M. T., McMaster, R. W., & Olivier, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001148 · Cited by 143
Tissue tropism in parasitic diseases
Silva Pereira, S., Trindade, S., De Niz, M., & Figueiredo, L. M. (2019) · Open Biology · doi:10.1098/rsob.190036 · Cited by 85
Leishmania major parasite stage‐dependent host cell invasion and immune evasion
Wenzel, U. A., Bank, E., Florian, C., Förster, S., Zimara, N., Steinacker, J., Klinger, M., Reiling, N., Ritter, U., & van Zandbergen, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-184895 · Cited by 52
“now used as promising novel vaccine candidates (6,7).”
Metadata
- Authors
- Zhang, W.-W., & Matlashewski, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-08-05
- Volume
- 94
- Issue
- 16
- Pages
- 8807-8811
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2166151377
- Cited by
- 153
- References
- 0
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.